SCHEMBL16514873

SCHEMBL16514873

C=CC(=O)Nc1cc(-c2cccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc23)ccn1.C=CC(=O)Nc1cc(-c2cccc3cnc(Nc4ccc(N5CCNCC5)cc4)nc23)ccn1.C=CC(=O)Nc1cc(-c2cccc3cnc(Nc4ccc(N5CCOCC5)cc4)nc23)ccn1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.61
FGFR2 P21802 1/20 0.59
FGFR1 P11362 2/20 0.58
KDR P35968 1/20 0.58
BTK Q06187 6/20 0.53
JAK2 O60674 5/20 0.52
JAK3 P52333 5/20 0.52
JAK1 P23458 3/20 0.52
TYK2 P29597 3/20 0.52
BRD4 O60885 1/20 0.52
MAP3K7 O43318 2/20 0.51
SRC P12931 1/20 0.51
MAP2K1 Q02750 1/20 0.50
BLK P51451 1/20 0.50
BMX P51813 1/20 0.50
FLT3 P36888 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16514927 0.92 EGFR (0.65) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16514536 0.92 EGFR (0.70) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16513680 0.91 EGFR (0.66) EGFRFGFR2FGFR1KDRBTK
SCHEMBL29847832 0.91 EGFR (0.66) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16515079 0.90 EGFR (0.63) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16515112 0.85 EGFR (0.83) EGFRFGFR2FGFR1KDRBTK
SCHEMBL28417563 0.84 FGFR1 (0.54) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16514018 0.84 FGFR2 (0.83) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16514260 0.83 EGFR (0.64) EGFRFGFR2FGFR1KDRBTK
SCHEMBL16514922 0.83 EGFR (0.85) EGFRFGFR2FGFR1KDRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP claimed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO claimed